Literature DB >> 26629198

Recent epidemiological and clinical features of acute hepatitis B in a single center of China.

Xiaohong Chen1, Chengtao Fu1, Jia Liu1, Lei Shan1, Chenglin Liu1.   

Abstract

AIM: This study was to investigate the epidemiological and clinical features of acute hepatitis B.
METHODS: A retrospective study of 177 acute hepatitis B patients with an average age of 36.03 years and range of 7-62 years was conducted from Jan 2005 to Feb 2011. The epidemiological and clinical parameters were investigated. The serological markers and biochemical tests were examined.
RESULTS: 76.84% (n = 136) patients were icteric type, while 23.16% (n = 41) were non-icteric type. Other clinical manifestations for acute hepatitis patients included fatigue (82.49%), gastrointestinal symptoms (66.10%), yellowish discoloration of skin and sclera, fever (31.07%), rash 10 (5.65%), joint pain (2.82%) and headache (1.69%). One case presented with acute renal failure associated with acute hepatitis B. Nine cases suffered from fulminant hepatitis. After treatment, hepatic function was significantly improved (P < 0.05). For serological markers, 54 (30.51%) and 119 (67.23%) patients had HBsAg and HBV-DNA seroconversion respectively. Four deaths occurred due to the severe complications associated by acute infection of HBV during half a year period follow up.
CONCLUSIONS: Adult males with occupation of workers and farmers are the high-risk population of acute hepatitis B in China. Several complications associated with acute hepatitis B should be noticed.

Entities:  

Keywords:  Acute hepatitis B; clinical features; complications; epidemiology

Year:  2015        PMID: 26629198      PMCID: PMC4659086     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

1.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

2.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

3.  A randomized controlled trial of lamivudine to treat acute hepatitis B.

Authors:  M Kumar; S Satapathy; R Monga; K Das; S Hissar; C Pande; B C Sharma; S K Sarin
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

Review 4.  Immunology of hepatitis B virus and hepatitis C virus infection.

Authors:  Barbara Rehermann; Michelina Nascimbeni
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

Review 5.  Hepatitis B virus infection.

Authors:  Mei-Hwei Chang
Journal:  Semin Fetal Neonatal Med       Date:  2007-02-28       Impact factor: 3.926

Review 6.  Epidemiology and prevention of hepatitis B.

Authors:  Miriam J Alter
Journal:  Semin Liver Dis       Date:  2003-02       Impact factor: 6.115

7.  Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.

Authors:  H Ring-Larsen; U Palazzo
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

8.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

9.  Acute renal failure associated with acute non-fulminant hepatitis B.

Authors:  Tomoya Kishi; Yuji Ikeda; Tsuyoshi Takashima; Shuichi Rikitake; Motoaki Miyazono; Shigehisa Aoki; Takanobu Sakemi; Toshihiko Mizuta; Kazuma Fujimoto
Journal:  World J Hepatol       Date:  2013-02-27

10.  Acute type A, B, and non-A, non-B hepatitis in a hospital population in London: clinical and epidemiological features.

Authors:  M Bamber; H C Thomas; B Bannister; S Sherlock
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.